Increased expression of heparan sulfate proteoglycan on the cultured renal epithelial cells during oxalate exposure

Kurume Medical Journal

Volumn 55, Issue 1-2, 2008, Pages 19-28

  Matsuo, Mitsunori ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Calcium oxalate; Cellular injury; Heparan sulfate proteoglycan; Nephrolithiasis; Syndecan 1

Indexed keywords

CALCIUM OXIDE; GLYCOSAMINOGLYCAN; MESSENGER RNA; OXALIC ACID; PROTEOHEPARAN SULFATE; SYNDECAN 1;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL LINE; CELL SURFACE; CELL VIABILITY; CONTROLLED STUDY; DOG; EPITHELIUM CELL; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOHISTOCHEMISTRY; KIDNEY CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; WILD TYPE;

EID: 56749161302     PISSN: 00235679     EISSN: 18812090     Source Type: Journal    
DOI: 10.2739/kurumemedj.55.19     Document Type: Article

References (38)

1. Suzuki K, and Ryall RL. The effect of heparan sulfate on the crystallization of calcium oxalate in undiluted, ultrafiltered human urine. Br J Urol 1996; 78:15-21.
2. Yamaguchi S, Yoshioka T, Utsunomiya M, Koide T, Osafune M et al. Heparan sulfate in the stone matrix and its inhibitory effect on calcium oxalate crystallization. Urol Res 1993; 21:187-192.
3. Ebisuno S, Kohjimoto Y, Tamura M, and Ohkawa T. Adhesion of calcium oxalate crystal to Madin-Darby canine kidney cells and some effects of glycosaminoglycans or cell injuries. Eur Urol 1995; 28:68-73.
4. Iida S, Miyajima J, Suzuki K, Matsuoka K, Inoue M et al. Expression of heparan sulfate proteoglycan mRNA in rat kidneys during calcium oxalate nephrolithiasis. Urol Res 1997; 25:361-364.
5. Iida S. Inoue M, Yoshii S, Yanagaki T, Chikama S et al. Molecular detection of heparan sulfate proteoglycan mRNA in rat kidney during calcium oxalate nephrolithiasis. J Am Soc Nephrol 1999; 10:S412-416.
6. Scheid C, Koul H, Hill WA, Luber-Narod J, Jonassen J et al. Oxalate toxicity in LLC-PK1 cells, a line of renal epithelial cells. J Urol 1996; 155:1112-1116.
7. Koul HK, Koul S, Fu S, Santosham V, Seikhon A et al. Oxalate: From crystal formation to crystal retention. J Am Soc Nephrol 1999; 10:S417-421.
8. Wiessner JH, Hasegawa AT, Hung LY, Mandel GS and Mandel NS. Mechanisms of calcium oxalate crystal attachment to injured renal collecting duct cells. Kidney International 2001; 59:637-644.
9. Verkoelen CF, Romijn JC, Cao LC, Boeve' ER, Bruijin WC et al. Crystal-cell interaction inhibition by polysaccharides. J Urol 1996; 155:749-752.
10. Gill WB, Jones KW, and Ruggiero KJ. Protective effects of heparin and other sulfated glycosaminoglycans on crystal adhesion to injured epithelium. J Urol 1982; 127:152-154.
11. Svennevig K, Prydz K, and Kolset SO. Proteoglycans in polarized epithelial Mardin-Darby canine kidney cells. Biochem J 1995; 311:881-888.
12. Chikama S, Iida S, Inoue M, Kawagoe N, Tomiyasu K et al. Role of heparan sulfate proteoglycan (syndecan-1) on the renal epithelial cells during calcium oxalate monohydrate crystal attachment. Kurume Med J 2002; 49:201-210.
13. Mali M, Jaakkola P, Arvilommi A-M, and Jalkanen M. Sequence of Human Syndecan Indicates a Novel Gene Family of Integral Membrane Proteoglycans. J Biol Chem 1990; 265:6884-6889.
14. Haendler B, Hofer-Warbinek R, and Hofer E. Complementary DNA for human T-cell cyclophilin. EMBO J 1987; 4:947-950.
15. Iida S, Peck AB, Johnson-Tardieu J, Moriyama M, Glenton PA et al. Temporal changes in mRNA expression for bikunin in the kidneys of rats during calcium oxalate nephrolithiasis. J Am Soc Nephrol 1999; 10:986-996.
16. Koji T, and Nakane PK. Recent advances in molecular histochemical techniques: in situ hybridization and southwestern histochemistry. J Electron Microscopy 1996; 45:119-127.
17. Yoshii A, Koji T, Ohsawa N, and Nakane PK. In situ localization of ribosomal RNAs is a reliable reference for hybridizable RNA in tissue sections. J Histochem Cytochem 1995; 43:321-327.
18. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Imm Met 1983; 65:55-63.
19. Heuvel LPWJ, Born J, Veerkamp JH, Velden TJAM, Schenkels L et al. Heparan sulfate proteoglycan from human tubular basement membrane. Comparison with this component from the glomerular basement membrane. Biochim Biophys Acta 1990; 1025:67-76.
20. Farquhar MG. The glomerular basement membrane: a selective macromolecular filter. In: Cell biology of extracellular matrix, ed. Hay ED. Plenum Press, New York, pp 335-378, 1981.
21. Farquhar MG, Lemkin MC, and Stow JL. Role of proteoglycans in glomerular function and pathology. In: Nephrology, ed. Robinson RR. Springer-Verlag, New York pp 580-600, 1985.
22. Tamsma JT, Van Den Born J, Bruijin JA, Assmann KJM, Weening JJ et al. Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulphate in the glomerular basement membrane. Diabetologia 1994; 37:313-320.
23. Bernfield M, Kokenyesi R, Kato M, Hinkes MT, Spring J et al. Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans. Annu Rev Cell Biol 1992; 8:365-393.
24. Jalkanen M. Biology of cell surface heparan sulfate proteoglycans. Med Biol 1987; 65:41-47.
25. Lieske JC, and Toback FG. Regulation of renal epithelial cell endocytosis of calcium oxalate monohydrate crystals. Am J Physiol 1993; 264:F800-807.
26. 2+. Urol Res 2003; 31:198-206.
27. 2+ mobilization. Am J Physiol 1998; 275:C832-839.
28. Khan SR. Calcium oxalate crystal interaction with renal tubular epithelium, mechanism of crystal adhesion and its impact on stone development. Urol Res 1995; 23:71-79.
29. Khan SR. Tubular cell surface events during nephrolithiasis. Curr Opin Urol 1997; 7:240-247.
30. Gokhale JA, Glenton PA, and Khan SR. Localization of tamm-horsfall protein and osteopontin in a rat nephrolithiasis model. Nephron 1996; 73:456-461.
31. Hammes MS, Lieske JC, Spargo BH, and Toback FG. Calcium oxalate monohydrate crystals stimulate gene expression in renal epithelial cells. Kidney International 1995; 48:501-509.
32. Lieske JC, Hammes MS, Hoyer JR, and Toback FG. Renal cell osteopontin production is stimulated by calcium oxalate monohydrate crystals. Kidney International 1997; 51:679-686.
33. Barsotti G, Cupisti A, Gervasi GB, Bartoli C, Barsotti M et al. Effects of oral administration of heparan sulphate in the rat remnant kidney model. Nephron 1999; 81:310-316.
34. Kohjimoto Y, Kennington L, Scheid CR, and Honeyman TW. Role of phospholipase A2 in the cytotoxic effects of oxalate in cultured renal epithelial cells. Kidney International 1999; 56:1432-1441.
35. Koul H, Kennington L, Nair G, Honeyman T, Menon M et al. Oxalate-induced initiation of DNA synthesis in LLC-PK1 cells, a line of renal epithelial cells. Biochem Biophys Res Commun 1994; 205:1632-1637.
36. Iida S, Peck AB, Byer KJ, and Khan SR. Expression of bikunin mRNA in renal epithelial cells after oxalate exposure. J Urol 1999; 162:1480-1486.
37. Umekawa T, Kohri K, Kurita T, Hirota S, Nomura S et al. Expression of osteopontin messenger RNA in the rat kidney on experimental model of renal stone. Biochem Mol Biol Int 1995; 35:223-230.
38. Grover PK, Miyazawa K, and Ryall RL. Renal prothrombin: quantification of mRNA using reverse transcription-polymerase chain reaction in a rat model. Electrophoresis 2004; 25:797-803.